首页> 外文OA文献 >TCT-211: The SYNTAX Trial at 3 Years: A Global Risk Approach to Identify Patients With 3-Vessel /or Left Main Stem Disease Who Could Safely Efficaciously Be Treated With Percutaneous Coronary Intervention Part 2: The All-Comers SYNTAX Population

【2h】

TCT-211: The SYNTAX Trial at 3 Years: A Global Risk Approach to Identify Patients With 3-Vessel /or Left Main Stem Disease Who Could Safely Efficaciously Be Treated With Percutaneous Coronary Intervention Part 2: The All-Comers SYNTAX Population

机译：TCT-211：3年期的SYNTAX试验：一种全球风险方法，用于确定经皮冠状动脉介入治疗可以安全有效地治疗3血管和/或左主干疾病的患者，第2部分：全民所有制SYNTAX人群

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者

展开▼
作者单位

展开▼
年度 2011
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A global risk approach to identify patients with left main or 3-vessel disease who could safely and efficaciously be treated with percutaneous coronary intervention: The SYNTAX trial at 3 years [J] . SerruysP.W., FarooqV., VranckxP., JACC. Cardiovascular interventions . 2012,第6期

机译：一种全球风险方法，以识别可以通过经皮冠状动脉介入治疗安全有效地治疗的左主干或三支血管疾病患者：SYNTAX试验（3年）
2. Letter by Al-Atassi et al Regarding Article, "Cost-Effectiveness of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Bypass Surgery for Patients With 3-Vessel or Left Main Coronary Artery Disease: Final Results From the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial" [J] . Al-Atassi Talal, Rodriguez Maria Lorena, Ruel Marc Circulation: An Official Journal of the American Heart Association . 2015,第1期

机译：Al-Atassi等人关于“ 3血管或左主冠状动脉疾病患者的经药物洗脱支架经皮冠状动脉介入治疗与旁路手术的成本效益：经皮冠状动脉介入与TAXUS协同作用的最终结果”和心脏外科手术（SYNTAX）试验”
3. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial. [J] . Morice MC, Serruys PW, Kappetein AP, Circulation: An Official Journal of the American Heart Association . 2010,第24期

机译：TAXUS经皮冠状动脉介入治疗与心脏外科手术之间的协同作用试验中，使用紫杉醇洗脱支架经皮冠状动脉介入治疗或使用冠状动脉搭桥术治疗的左新发主要疾病患者的结局。
4. Risk-prediction models for CABG of coronary artery left-main disease and EuroScore in Chinese patients in Taiwan [C] . Chen R.J., Wei J., Chang C.Y., International Congress on Coronary Artery Disease . 2009

机译：台湾中国患者冠状动脉左派患者CABG风险预测模型
5. SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous Coronary Intervention in the Contemporary Cobalt-Chromium Everolimus-Eluting Stent Era [O] . Jeehoon Kang, Jung-Kyu Han, Do-Yoon Kang, 2020

机译：SYNTAX评分和SYNTAX评分II可以预测当代钴-铬依维莫司洗脱支架时代接受经皮冠状动脉介入治疗的左主干和/或3血管疾病患者的临床结果。
6. A Global Risk Approach to Identify Patients With Left Main or 3-Vessel Disease Who Could Safely and Efficaciously Be Treated With Percutaneous Coronary Intervention The SYNTAX Trial at 3 Years [O] . Serruys Patrick W., Farooq Vasim, Vranckx Pascal, 2012

机译：一项全球风险方法来确定可以通过经皮冠状动脉介入治疗安全有效地治疗左主干或三支血管疾病的患者3年的SYNTAX试验

TCT-211: The SYNTAX Trial at 3 Years: A Global Risk Approach to Identify Patients With 3-Vessel /or Left Main Stem Disease Who Could Safely Efficaciously Be Treated With Percutaneous Coronary Intervention Part 2: The All-Comers SYNTAX Population

著录项

相似文献

相关主题

期刊订阅